Publication,

Doing Business in Spain 2018 (Bilingual)

Current site :    CN   |   EN
Australia
Belgium
China
China Hong Kong SAR
Germany
Italy
Japan
Singapore
Spain
UAE
United Kingdom
United States
Global

As the 13th largest global economy and the gateway to Africa and South America, Spain offers a wide range of opportunities for Chinese outbound investors. In the past several years, the Chinese government has attached importance to growing its relationship with Spain, with China citing Spain's open and price competitive market along with a co-operative regulatory framework as the principal reasons behind the desire to do business.

Spain presents some of Europe's most exciting investment opportunities. Doing Business in Spain provides perspectives on the major market opportunities for Chinese investors, including:

  • The investment environment and target sectors for investment

  • Current trends in Spanish mergers and acquisitions; and

  • The key themes and legal issues that are shaping today's market.


    * KWM global network has produced a series publications in doing business overseas, which can also be accessed via website or intranet. These include

"Doing Business in China" (EN) 

DOWNLOAD PUBLICATION
Doing Business in Spain
This pamphlet explores opportunities for Chinese investors in Spain and analyses legal issues that may arise to help clients navigate the local market.

Download

6.89MB, 36 Pages

LATEST THINKING
Insight
New regulations in China designed to encourage innovation in clinical trials have made it easier to test human samples in a lab setting.

19 May 2022

Publication
Since 2017, KWM has issued the Series, Think Tank Report: Law and Practice under the Belt and Road Initiative. As the fifth instalment of the Series, this pamphlet comprises two parts: “Overview” and “Introduction by Countries”. Authored by KWM lawyers focusing on investment, financing, construction and projects, M&A, trade, compliance, and dispute resolution, this pamphlet will present you our experience and insights from different perspectives.

14 May 2022

Insight
Under the Chinese medical device regulatory regime, as filing/registration is compulsory prior to marketization, the legality of use of unregistered in vitro diagnostics reagents (“IVD”) in laboratory-developed testing (“LDT”) has been in a grey area for a long time.

10 May 2022